← FDA Drug Approvals (Drugs@FDA)

UPTRAVI

NDA · New Drug Application · Sponsor: ACTELION · Approved 2015-12-21

Drug application

FDA Application #

NDA207947

Application type

New Drug Application

Brand name

UPTRAVI

Generic name

SELEXIPAG

Active ingredients

SELEXIPAG

Dosage form

TABLET

Route

ORAL

Marketing status

Prescription

Sponsor

ACTELION

Manufacturer

Actelion Pharmaceuticals US, Inc.

First approval

2015-12-21

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown